Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 01/17/23 07:20:00 on US and Canada Markets.
VANCOUVER, British Columbia, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Alpha Lithium Corporation (NEO: ALLI) (OTC: APHLF) (German WKN: A3CUW1) (“Alpha” or the “Company”), a company with two large, undeveloped lithium assets in the Salta region of Argentina, is pleased to repor...
Cargojet extends Master Services Agreement with Canada Post Corporation and Purolator Inc. until 2029 Canada NewsWire Strategic Renewal with Canada Post Corporation and Purolator Inc. reinforces Cargojet's Leadership Position in the Domestic Air Cargo Market MISSISSA...
Appili Therapeutics has named Dr. Carl Gelhaus as Director of Non-Clinical Research and Arthur Baran as Director of New Product Development for the ATI-1701 program. Appili Therapeutics Inc. (TSX: APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmace...
Appili Therapeutics has named Dr. Carl Gelhaus as Director of Non-Clinical Research and Arthur Baran as Director of New Product Development for the ATI-1701 program. Appili Therapeutics Inc. (TSX: APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmace...
MELBOURNE, Australia, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases, is plea...
NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its gene editing platform to deliver life-saving cell and gene therapies, announced today that Cibus Global LLC, a Delaware limited liability company (ȁ...
NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its gene editing platform to deliver life-saving cell and gene therapies, announced today that Cibus Global LLC, a Delaware limited liability company (ȁ...
NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its gene editing platform to deliver life-saving cell and gene therapies, announced today that Cibus Global LLC, a Delaware limited liability company (ȁ...
First Mining Provides Springpole Exploration Update on District-Scale Birch-Uchi Greenstone Belt Canada NewsWire District exploration programs returned high-grade gold mineralization in rock sampling up to 42.4 g/t Au, favourable soil geochemistry anomalies and saw the complet...
First Mining Provides Springpole Exploration Update on District-Scale Birch-Uchi Greenstone Belt Canada NewsWire District exploration programs returned high-grade gold mineralization in rock sampling up to 42.4 g/t Au, favourable soil geochemistry anomalies and saw the complet...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
22.75%Change Percent:
Precipio Inc. Company Name:
PRPO Stock Symbol:
NASDAQ Market:
precipiodx.com Website: